Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Recently Approved Breakthrough Therapies

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 9 of 9
Recently Approved Breakthrough Therapies
Introduction
Ashley F Ward
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on April 2, 2019 1:00 PM-2:45 PM
Recently Approved Breakthrough Therapies
Tisagenlecleucel
Roger J. Kurlander
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on April 2, 2019 1:00 PM-2:45 PM
Recently Approved Breakthrough Therapies
Tisagenlecleucel
Saad J Kenderian
Mayo Clinic, Rochester, MN, United States
from AACR Annual Meeting 2019 on April 2, 2019 1:00 PM-2:45 PM
Recently Approved Breakthrough Therapies
Tagraxofusp
Emily Y. Jen
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on April 2, 2019 1:00 PM-2:45 PM
Recently Approved Breakthrough Therapies
Tagraxofusp
Naveen Pemmaraju
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2019 on April 2, 2019 1:00 PM-2:45 PM
Recently Approved Breakthrough Therapies
Mogamulizumab
Yvette Kasamon
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on April 2, 2019 1:00 PM-2:45 PM
Recently Approved Breakthrough Therapies
Mogamulizumab
Lauren Pinter-Brown
University of California Irvine, Irvine, CA, United States
from AACR Annual Meeting 2019 on April 2, 2019 1:00 PM-2:45 PM
Recently Approved Breakthrough Therapies
Larotrectinib
Leigh Marcus
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on April 2, 2019 1:00 PM-2:45 PM
Recently Approved Breakthrough Therapies
Larotrectinib
David Hyman
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2019 on April 2, 2019 1:00 PM-2:45 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 9 of 9